Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Alibaba Group Holding Limited (BABA) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alibaba Group Holding Limited (BABA) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for October 15th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 15th:
Orla Mining Ltd. (ORLA - Free Report) : This mining company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.
Orla Mining Ltd. Price and Consensus
Orla Mining Ltd. price-consensus-chart | Orla Mining Ltd. Quote
Orla’ shares gained 8.6% over the last three months compared with the S&P 500’s advance of 3.4%. The company possesses a Momentum Score of A.
Orla Mining Ltd. Price
Orla Mining Ltd. price | Orla Mining Ltd. Quote
Alibaba Group Holding Limited (BABA - Free Report) : This Chinese e-commerce giant has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.
Alibaba Group Holding Limited Price and Consensus
Alibaba Group Holding Limited price-consensus-chart | Alibaba Group Holding Limited Quote
Alibaba’s shares gained 37.6% over the last three months compared with the S&P 500’s advance of 3.4%. The company possesses a Momentum Score of A.
Alibaba Group Holding Limited Price
Alibaba Group Holding Limited price | Alibaba Group Holding Limited Quote
PDS Biotechnology Corporation (PDSB - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
PDS Biotechnology Corporation Price and Consensus
PDS Biotechnology Corporation price-consensus-chart | PDS Biotechnology Corporation Quote
PDS’ shares gained 17.2% over the last six months compared with the S&P 500’s advance of 16.1%. The company possesses a Momentum Score of A.
PDS Biotechnology Corporation Price
PDS Biotechnology Corporation price | PDS Biotechnology Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.